Nucleic acid nanorobot assay for accurate and simplified ASO quantification in mouse plasma

Åsa Sandelius; C.H. Arrowsmith; Neil Henderson; Alexander W. Jackson

doi:10.1080/17576180.2025.2597181

Abstract

A NAN assay for ASO PK bioanalysis was for the first time assessed for performance and agreement between laboratories, demonstrating this as a viable additional alternative to current bioanalytical methodologies.

Affiliated Institutions

AstraZeneca (Sweden) SE

Related Publications

Evaluating New Cardiovascular Risk Factors for Risk Stratification

Ralph H. Stern

There is an active debate on the best approach to evaluate new cardiovascular risk factors. The divergent views have been most clearly laid out in the case of C-reactive protein...

2008 Journal of Clinical Hypertension 19 citations

Publication Info

Year: 2025
Type: article
Pages: 1-9
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Nucleic acid nanorobot assay for accurate and simplified ASO quantification in mouse plasma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Åsa Sandelius, 
                                
                                    C.H. Arrowsmith, 
                                
                                    Neil Henderson
                                
                                et al.
                            
                            (2025). 
                            Nucleic acid nanorobot assay for accurate and simplified ASO quantification in mouse plasma. 
                            Bioanalysis
                            
                            , 1-9.
                            https://doi.org/10.1080/17576180.2025.2597181

Identifiers

DOI: 10.1080/17576180.2025.2597181